BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 37952690)

  • 21. Regulation of Podocyte Injury by CircHIPK3/FUS Complex in Diabetic Kidney Disease.
    Liu F; Huang J; Zhang C; Xie Y; Cao Y; Tao L; Tang H; Lin J; Hammes HP; Huang K; Yi F; Su H; Zhang C
    Int J Biol Sci; 2022; 18(15):5624-5640. PubMed ID: 36263181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Four-and-a-Half LIM Domains Protein 2 Is a Coactivator of Wnt Signaling in Diabetic Kidney Disease.
    Li SY; Huang PH; Tarng DC; Lin TP; Yang WC; Chang YH; Yang AH; Lin CC; Yang MH; Chen JW; Schmid-Schönbein GW; Chien S; Chu PH; Lin SJ
    J Am Soc Nephrol; 2015 Dec; 26(12):3072-84. PubMed ID: 25855776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Research advance in the mechanism for oxidative stress-induced podocyte injury in diabetic kidney disease.
    Ao L; Xie Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 46(12):1403-1408. PubMed ID: 35232911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic or pharmacologic blockade of mPGES-2 attenuates renal lipotoxicity and diabetic kidney disease by targeting Rev-Erbα/FABP5 signaling.
    Zhong D; Chen J; Qiao R; Song C; Hao C; Zou Y; Bai M; Su W; Yang B; Sun D; Jia Z; Sun Y
    Cell Rep; 2024 Apr; 43(4):114075. PubMed ID: 38583151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dysregulated expression but redundant function of the long non-coding RNA HOTAIR in diabetic kidney disease.
    Majumder S; Hadden MJ; Thieme K; Batchu SN; Niveditha D; Chowdhury S; Yerra VG; Advani SL; Bowskill BB; Liu Y; Vakili H; Alghamdi TA; White KE; Geldenhuys L; Siddiqi FS; Advani A
    Diabetologia; 2019 Nov; 62(11):2129-2142. PubMed ID: 31399844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. STIM promotes the epithelial-mesenchymal transition of podocytes through regulation of FcγRII activity in diabetic nephropathy.
    Jin J; Ye M; Hu K; Gong J; He Q
    Histol Histopathol; 2019 Jun; 34(6):671-682. PubMed ID: 30475382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vitamin D Ameliorates Podocyte Injury by Enhancing Autophagy Activity in Diabetic Kidney Disease.
    Zhang X; Zhang L; Wen Y; Zhang M; Liu S; Xiao H
    Kidney Blood Press Res; 2023; 48(1):314-325. PubMed ID: 37054686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modified Hu-lu-ba-wan protects diabetic glomerular podocytes via promoting PKM2-mediated mitochondrial dynamic homeostasis.
    Gong M; Guo Y; Dong H; Wu F; He Q; Gong J; Lu F
    Phytomedicine; 2024 Jan; 123():155247. PubMed ID: 38128393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Inhibition of Histone Deacetylase 6 Ameliorates Podocyte Injury in Diabetic Kidney Disease in Mice].
    Hou Q; Kan S; Zhang M; Xu F; Liu Z; Jiang S
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Nov; 54(6):1097-1104. PubMed ID: 38162083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inflammatory stress exacerbates lipid accumulation and podocyte injuries in diabetic nephropathy.
    Zhang Y; Ma KL; Liu J; Wu Y; Hu ZB; Liu L; Lu J; Zhang XL; Liu BC
    Acta Diabetol; 2015 Dec; 52(6):1045-56. PubMed ID: 25896009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein tyrosine phosphatase 1B deficiency in podocytes mitigates hyperglycemia-induced renal injury.
    Ito Y; Hsu MF; Bettaieb A; Koike S; Mello A; Calvo-Rubio M; Villalba JM; Haj FG
    Metabolism; 2017 Nov; 76():56-69. PubMed ID: 28987240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Crosstalk Between Lipids and Mitochondria in Diabetic Kidney Disease.
    Ducasa GM; Mitrofanova A; Fornoni A
    Curr Diab Rep; 2019 Nov; 19(12):144. PubMed ID: 31754839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ATP-binding cassette A1 deficiency causes cardiolipin-driven mitochondrial dysfunction in podocytes.
    Ducasa GM; Mitrofanova A; Mallela SK; Liu X; Molina J; Sloan A; Pedigo CE; Ge M; Santos JV; Hernandez Y; Kim JJ; Maugeais C; Mendez AJ; Nair V; Kretzler M; Burke GW; Nelson RG; Ishimoto Y; Inagi R; Banerjee S; Liu S; Szeto HH; Merscher S; Fontanesi F; Fornoni A
    J Clin Invest; 2019 Jul; 129(8):3387-3400. PubMed ID: 31329164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipin-1 deficiency deteriorates defect of fatty acid β-oxidation and lipid-related kidney damage in diabetic kidney disease.
    Lin S; Wang L; Jia Y; Sun Y; Qiao P; Quan Y; Liu J; Hu H; Yang B; Zhou H
    Transl Res; 2024 Apr; 266():1-15. PubMed ID: 37433392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Podocyte-Specific Loss of Krüppel-Like Factor 6 Increases Mitochondrial Injury in Diabetic Kidney Disease.
    Horne SJ; Vasquez JM; Guo Y; Ly V; Piret SE; Leonardo AR; Ling J; Revelo MP; Bogenhagen D; Yang VW; He JC; Mallipattu SK
    Diabetes; 2018 Nov; 67(11):2420-2433. PubMed ID: 30115650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Berberine protects against diabetic kidney disease via promoting PGC-1α-regulated mitochondrial energy homeostasis.
    Qin X; Jiang M; Zhao Y; Gong J; Su H; Yuan F; Fang K; Yuan X; Yu X; Dong H; Lu F
    Br J Pharmacol; 2020 Aug; 177(16):3646-3661. PubMed ID: 31734944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tripterygium glycoside protects diabetic kidney disease mouse serum-induced podocyte injury by upregulating autophagy and downregulating β-arrestin-1.
    Zhan H; Jin J; Liang S; Zhao L; Gong J; He Q
    Histol Histopathol; 2019 Aug; 34(8):943-952. PubMed ID: 30839094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tripterygium glycoside suppresses epithelial‑to‑mesenchymal transition of diabetic kidney disease podocytes by targeting autophagy through the mTOR/Twist1 pathway.
    Tao M; Zheng D; Liang X; Wu D; Hu K; Jin J; He Q
    Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34165172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Macrophage inflammatory protein-1β as a novel therapeutic target for renal protection in diabetic kidney disease.
    Chang TT; Li SY; Lin LY; Chen C; Chen JW
    Biomed Pharmacother; 2023 May; 161():114450. PubMed ID: 36863097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of mitochondrial fission protects podocytes from albumin-induced cell damage in diabetic kidney disease.
    Tagaya M; Kume S; Yasuda-Yamahara M; Kuwagata S; Yamahara K; Takeda N; Tanaka Y; Chin-Kanasaki M; Nakae Y; Yokoi H; Mukoyama M; Ishihara N; Nomura M; Araki SI; Maegawa H
    Biochim Biophys Acta Mol Basis Dis; 2022 May; 1868(5):166368. PubMed ID: 35202791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.